HCPLive

Top Medical News Today

Improving the Future of Care for Heart Disease
There have been great strides made in recent years to help treat patients diagnosed with heart disease. As technology improves and new medications are developed it will be important to ensure they can get to the patients who need them most.
As Zika cases mount, US funds a second vaccine project. Sanofi Pasteur and Walter Reed Army Research are getting $43.18 million. There are now at least 749 pregnant women in the US States with known Zika infections.
While lifestyle modifications and changes in diet can help prevent heart disease in men and women alike there are some distinct differences when it comes to treating these patients once a diagnosis is made.
As more has been learned over the years about heart disease there is also a greater awareness of the impact it can have on women. Because of this increased awareness a greater effort is underway to help catch these conditions before they become fatal.
A graft consisting of a monolayer sheet of RPE or a complex graft of RPE and Bruch’s membrane were found equally effective in restoring visual function and central fixation stability.
The drug, a fully human monoclonal antibody that has impressed equally in asthma and atopic dermatitis trials, may be approved for market as soon as March of 2017.
In the field of neurosurgery it can seem like each new day is the future. Even still there are goals to achieve that may not be reached until many years down the road.
Even though some medications for epilepsy are able to drastically reduce the number of seizures a patient suffers sometimes just one can be damaging enough to a person's quality of life.
As new medications have been approved for movement disorders like Parkinson's Disease many patients have been able to better manage their symptoms. When that is not enough newer surgical options have also been developed in recent years.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$